Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -12.14%24.4M | -23.21%21.53M | -16.37%23.18M | -1.62%112.17M | -3.98%28.64M | -1.89%27.77M | 1.52%28.03M | -1.92%27.72M | -4.37%114.01M | 9.45%29.83M |
| Cost of revenue | -15.68%14.22M | -25.47%12.76M | -13.71%14.07M | 4.60%64.11M | 18.20%13.82M | 3.12%16.87M | 6.64%17.12M | -5.14%16.3M | -11.27%61.29M | -4.23%11.7M |
| Gross profit | -6.68%10.18M | -19.66%8.77M | -20.17%9.12M | -8.85%48.06M | -18.28%14.82M | -8.74%10.91M | -5.60%10.91M | 3.08%11.42M | 5.15%52.72M | 20.57%18.13M |
| Operating expense | -16.87%12.68M | -24.09%11.22M | -12.31%12.58M | 4.57%55.62M | -11.93%11.84M | 15.02%15.25M | 13.44%14.78M | 9.86%14.34M | 7.91%53.19M | -7.03%13.44M |
| Staff costs | ---- | ---- | ---- | 0.72%43.67M | ---- | ---- | ---- | ---- | 9.44%43.36M | ---- |
| Depreciation and amortization | ---- | ---- | ---- | 4.73%3.89M | ---- | ---- | ---- | ---- | 19.24%3.71M | ---- |
| -Depreciation | ---- | ---- | ---- | 5.35%2.36M | ---- | ---- | ---- | ---- | 46.52%2.24M | ---- |
| -Amortization | ---- | ---- | ---- | 3.80%1.53M | ---- | ---- | ---- | ---- | -7.06%1.47M | ---- |
| Other operating expenses | -16.87%12.68M | -14.82%12.64M | -11.48%13.24M | 19.77%8.65M | -12.58%11.91M | 14.78%15.25M | 9.36%14.84M | 11.62%14.96M | -12.57%7.22M | 147.11%13.62M |
| Total other operating income | ---- | 2,029.85%1.43M | 7.93%667K | -46.61%589.2K | -60.44%72K | ---- | -87.75%67K | 77.59%618K | -35.24%1.1M | 128.31%182K |
| Operating profit | 42.45%-2.5M | 36.60%-2.45M | -18.42%-3.46M | -1,528.07%-7.56M | -36.47%2.98M | -231.86%-4.34M | -163.35%-3.87M | -47.92%-2.92M | -154.31%-464.28K | 702.62%4.69M |
| Net non-operating interest income (expenses) | -83.33%-88K | -89.13%-87K | -48.21%-83K | -25.85%-284.86K | -207.94%-194K | 21.31%-48K | 22.03%-46K | -30.23%-56K | -65.32%-226.35K | -110.60%-63K |
| Non-operating interest expense | 83.33%88K | 89.13%87K | 48.21%83K | 25.85%284.86K | 207.94%194K | -21.31%48K | -22.03%46K | 30.23%56K | 65.32%226.35K | 110.60%63K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0 | 0 | 0 | 41.48%-249.5K | 37.50%-45K | 94.19%-5K | 64.35%-41K | -3.92%-159K | -652.52%-426.35K | -161.36%-72K |
| Special income (charges) | -333.26%-948.12K | 321.01%406.47K | ||||||||
| Less:Write off | ---- | ---- | ---- | 333.26%948.12K | ---- | ---- | ---- | ---- | -321.01%-406.47K | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 41.14%-2.59M | 35.80%-2.54M | -12.95%-3.54M | -1,172.52%-9.04M | -39.83%2.74M | -201.99%-4.4M | -140.74%-3.95M | -44.47%-3.14M | -248.84%-710.51K | 833.54%4.56M |
| Income tax | 51.52%-191K | 80.10%-41K | -211.20%-288K | -54.97%656.81K | 46.12%998K | -258.23%-394K | -176.87%-206K | 0.00%259K | 31.69%1.46M | 852.97%683K |
| Net income | 40.12%-2.4M | 33.36%-2.5M | 4.15%-3.25M | -347.08%-9.7M | -54.98%1.75M | -134.78%-4M | -96.18%-3.75M | -39.73%-3.39M | -244.15%-2.17M | 830.20%3.88M |
| Net income continuous operations | 40.12%-2.4M | 33.36%-2.5M | 4.15%-3.25M | -347.08%-9.7M | -54.98%1.75M | -134.78%-4M | -96.18%-3.75M | -39.73%-3.39M | -244.15%-2.17M | 830.20%3.88M |
| Noncontrolling interests | 55.44%-254K | 43.11%-285K | 180.39%541K | -95.80%-2.09M | -214.90%-347K | -29.84%-570K | -23.40%-501K | -28.19%-673K | -93.67%-1.07M | 3,082.97%302K |
| Net income attributable to the company | 37.58%-2.14M | 31.85%-2.21M | -39.43%-3.79M | -590.83%-7.61M | -41.45%2.09M | -171.17%-3.43M | -115.82%-3.25M | -42.91%-2.72M | -1,297.25%-1.1M | 777.46%3.57M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 37.58%-2.14M | 31.85%-2.21M | -39.43%-3.79M | -590.83%-7.61M | -41.45%2.09M | -171.17%-3.43M | -115.82%-3.25M | -42.91%-2.72M | -1,297.25%-1.1M | 777.46%3.57M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 37.40%-0.0154 | 31.76%-0.0159 | -39.49%-0.0272 | -591.14%-0.0546 | -41.41%0.015 | -170.33%-0.0246 | -115.74%-0.0233 | -42.34%-0.0195 | -1,216.67%-0.0079 | 782.76%0.0256 |
| Diluted earnings per share | 37.40%-0.0154 | 31.76%-0.0159 | -39.49%-0.0272 | -591.14%-0.0546 | -41.41%0.015 | -170.33%-0.0246 | -115.74%-0.0233 | -42.34%-0.0195 | -1,216.67%-0.0079 | 782.76%0.0256 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.